MDCN — Medican Enterprises Share Price
Last trade - 00:00- $0.04m
- $7.80m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2010 | 2011 | 2012 | 2013 | 2014 | 2015E | 2016E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medican Enterprises Inc. is focused on sports and entertainment, holding investments that includes stakes in basketball franchises, digital media assets and sports related NFT's. Its products include basketball team ownership, sports real estate interests, media content and digital collectibles. It has ownership stakes in professional basketball teams (Hollywood Action, Beverly Hills Majestics and American Basketball Association Canada Inc.). The Company's sports real estate interests include investment in ABA Sports Realty Group, offering access to sports-related real estate opportunities. Its media content product includes rights to the Fathers of the Sport video game and documentary, providing sports-related storytelling and content. Its digital collectibles include associated NFTs and digital assets tied to the Fathers of the Sportbrand and other basketball-related properties. Its services include sports management, content production & licensing and sports investment & consulting.
Directors
- Last Annual
- December 31st, 2014
- Last Interim
- March 31st, 2015
- Incorporated
- October 27th, 1988
- Public Since
- May 22nd, 2000
- No. of Shareholders
- 197
- No. of Employees
- 3
- Sector
- Hotels & Entertainment Services
- Industry
- Consumer Cyclicals
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 38,944,976,286
- Address
- 3440 E. Russell Road, RENO, 89501-2290
- Web
- Phone
- +1 7028263365
- Auditors
- Anton & Chia, LLP
Upcoming Events for MDCN
Similar to MDCN
Archon
Pink Sheets on Nasdaq
Agassi Sports Entertainment
Pink Sheets on Nasdaq
Agrieuro
Pink Sheets on Nasdaq
Amergent Hospitality
Pink Sheets on Nasdaq
American Graphite Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 21:58 UTC, shares in Medican Enterprises are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Medican Enterprises last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Medican Enterprises share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out moreMedican Enterprises does not currently pay a dividend.
Medican Enterprises does not currently pay a dividend.
Medican Enterprises does not currently pay a dividend.
To buy shares in Medican Enterprises you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Medican Enterprises had a market capitalisation of $0.04m.
Here are the trading details for Medican Enterprises:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MDCN
Based on an overall assessment of its quality, value and momentum Medican Enterprises is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medican Enterprises. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.00, shares in Medican Enterprises were trading -82.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medican Enterprises PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medican Enterprises' management team is headed by:
- Kenneth Williams - CHM
- Wayne Hansen - CFO
- Michael Thompson - IND